Anna

(redirected from antibody)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to antibody: monoclonal antibody

Anna

A customary unit of area approximately equivalent to 16.86 square meters. It is used in real estate transactions in some parts of Pakistan.
Mentioned in ?
References in periodicals archive ?
The EvoGenix technology can convert a research-stage antibody into a high potency therapeutic suitable for long term administration to patients.
Antibody titers to CHIKV were measured by hemagglutination-inhibition (HI) assay in all 2,000 cord serum samples.
The acquisition of sensitization depends therefore on the initiation of an immune response of sufficient vigor and of the quality required to sustain IgE antibody production.
That was part of the reason I decided to stay away from polyclonal sera [such as antibody preparations made from the blood of persons whose HIV was progressing slowly].
CAT's SVP Drug Discovery, commented, "This combination of CAT's display technologies and the VelocImmune platform will provide enormous potential for creating antibody therapeutics.
Recent innovations in high throughput production of antibodies from genetic antigens will complement the company's established leadership in commercial and custom antibody production for the Research, Human/Animal Diagnostics, and Pharmaceutical industries, and position the company for broader participation in the pharmacogenomics market.
This antibody response was only poorly induced by infection, both in mice (22) and humans (24,25).
Until this year, most evidence that antibody therapy might work came from laboratory studies in animals.
These new transcripts can then be studied further for their role in disease by using the newly discovered sequence as antigen information within the Genomic Antibodies[TM] platform to create novel antibody tools.
The S protein is the major surface antigen of the virus, and the neutralizing antibody response is primarily directed against this protein.
To maintain and expand our leadership in the antibody market, and in disease areas such as oncology, Roche will continue to partner with excellent antibody companies such as GLYCART.
In the April Nature Immunology, two other reports provide some insight into how an antibody response to GPI can afflict joints but not other tissues containing that protein.

Full browser ?